Suppr超能文献

根据血浆中四氢大麻酚(THC)和四氢大麻酚羧酸(THCCOOH)的浓度估算最后一次口服大麻的时间。

Estimating time of last oral ingestion of cannabis from plasma THC and THCCOOH concentrations.

作者信息

Huestis Marilyn A, Elsohly Mahmoud, Nebro Wesenyalsh, Barnes Allan, Gustafson Richard A, Smith Michael L

机构信息

Chemistry and Drug Metabolism, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, USA.

出版信息

Ther Drug Monit. 2006 Aug;28(4):540-4. doi: 10.1097/00007691-200608000-00009.

Abstract

Estimating the time of last cannabis use is important in assessing possible impairment of drivers involved in accidents, in verifying accuracy of court testimony and in the future, helpful in therapeutic monitoring of cannabis agonists. In 1992, Huestis et al developed model 1, based on plasma Delta-tetrahydrocannabinol (THC) concentrations, and model 2, on plasma 11-nor-9-carboxy-Delta(9)-tetrahydrocannbinol/THC ratios, that predicted 95% confidence intervals for time of last cannabis use. These models seemed to be valuable when applied to the small amount of data from published studies of oral ingestion, a route of administration more popular with the advent of cannabis therapies. A study was designed to further validate the models after oral ingestion of THC, and to determine whether they could predict last usage after multiple oral doses. Eighteen subjects in IRB-approved studies participated after providing informed consent. Each of 12 subjects in one group received a single 10 mg oral dose of dronabinol (synthetic THC). In another protocol, 6 subjects received 4 different oral daily doses, divided into thirds and administered with meals for 5 consecutive days. There was a 10-day washout period between each dosing regimen. Daily doses were 0.39, 0.47, and 14.8 mg THC in hemp oil and 7.5 mg dronabinol. Blood specimens were collected throughout the study and analyzed for plasma THC and 11-nor-9-carboxy-Delta(9)-tetrahydrocannbinol by gas chromatography/mass spectrometry with limits of quantification (LOQs) of 0.5 and 1.0 ng/mL, respectively. Actual times between ingestion of THC and blood collection spanned 0.5 to 16 hours. All plasma specimens with analyte concentrations >LOQ (n=90) were evaluated. Models 1 and 2 correctly predicted time of last THC ingestion for 74.4% and 90.0% of plasma specimens, respectively. 96.7% of predicted times were correct with one overestimate and 2 underestimates using the time interval defined by the lowest and highest 95% confidence limit of both models. These results provide further evidence of the usefulness of the predictive models in estimating the time of last oral THC ingestion after single or multiple doses.

摘要

估算最后一次使用大麻的时间对于评估涉及事故的驾驶员可能存在的驾驶能力受损情况、核实法庭证词的准确性以及未来对大麻激动剂的治疗监测都很重要。1992年,休斯蒂斯等人基于血浆Δ-四氢大麻酚(THC)浓度开发了模型1,并基于血浆11-去甲-9-羧基-Δ⁹-四氢大麻酚/THC比值开发了模型2,这些模型可预测最后一次使用大麻时间的95%置信区间。当将这些模型应用于已发表的口服摄入研究中的少量数据时,它们似乎很有价值,随着大麻疗法的出现,口服摄入这种给药途径越来越普遍。一项研究旨在进一步验证口服THC后的模型,并确定它们是否能预测多次口服给药后的最后使用时间。18名受试者在获得机构审查委员会批准的研究中提供知情同意后参与。一组中的12名受试者每人接受了单次10毫克口服剂量的屈大麻酚(合成THC)。在另一个方案中,6名受试者接受了4种不同的每日口服剂量,分成三等份并与餐同服,连续服用5天。每种给药方案之间有10天的洗脱期。每日剂量分别为大麻油中的0.39、0.47和14.8毫克THC以及7.5毫克屈大麻酚。在整个研究过程中采集血样,并通过气相色谱/质谱法分析血浆THC和11-去甲-9-羧基-Δ⁹-四氢大麻酚,定量限(LOQs)分别为0.5和1.0纳克/毫升。THC摄入与采血之间的实际时间跨度为0.5至16小时。对所有分析物浓度>LOQ的血浆样本(n = 90)进行了评估。模型1和模型2分别正确预测了74.4%和90.0%的血浆样本的最后一次THC摄入时间。使用两个模型的最低和最高95%置信限定义的时间间隔,96.7%的预测时间是正确的,有1次高估和2次低估。这些结果进一步证明了预测模型在估算单次或多次给药后最后一次口服THC摄入时间方面的有用性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验